Neurotrophin signaling through the p75 neurotrophin receptor.

By Philippe P Roux, P. Barker. Progress in neurobiology, 2002

751 citations recorded by the source corpus.

Subfields: Cancer Research, Cellular and Molecular Neuroscience, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/aa9ef4f4b6edea6320e5ed2f2ae5f9beb7188b2d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Undurti N. Das
2. M. Chao
3. Siresha Bathina

In Cellular and Molecular Neuroscience

1. Anita E. Autry
2. L. Monteggia
3. Undurti N. Das
4. Siresha Bathina
5. Helen M. Blau
6. Volkmar Lessmann
7. M. Chao
8. K. Gottmann

In Molecular Biology

1. Undurti N. Das
2. Helen M. Blau
3. Volkmar Lessmann
4. M. Chao
5. Anita E. Autry
6. L. Monteggia
7. K. Gottmann
8. M. Malcangio

Citations in the corpus

• Neurotrophins and their receptors: A convergence point for many signalling pathways (2003, background): “In addition to forming complexes, Trk and p75 receptors show independent signalling propertie”
• Brain-derived neurotrophic factor and its clinical implications (2015, background): “Trk receptor-mediated signaling is controlled through expression of intermediates in these signaling pathways that regulate localization of different signaling constituents [21–23].”
• Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. (2007, background): “Nerve Growth Factor is the founding member of the neurotrophins, which are a family of secreted proteins essential for the proper development, patterning, and maintenance of the mammalian nervous system (Bothwell, 1995; Chao, 2003; Cohen, 1959; Dechant and Barde, 2002; Roux and Barker, 2002).”
• Neurotrophin secretion: current facts and future prospects. (2003, background): “The present knowledge about these two types of receptors and the intracellular signaling mechanisms that follow their activation has been extensively reviewed elsewhere (see, e.g.Kaplan and Miller, 2000; Patapoutian and Reichardt, 2001; Roux and Barker, 2002) and will not be addressed here.”
• Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders (2012, background): “Schizophrenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246 A. Brain-derived neurotrophic factor and schizophrenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246 B.…”